AI
ALT icon

Atom Investors’s Altimmune ALT Stock Holding History

Atom Investors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,412
Closed -$308K – 566
2023
Q4 		$308K Buy
+27,412
New +$114K 0.05% 353
2022
Q4 		– Sell
-26,818
Closed -$342K – 222
2022
Q3 		$342K Sell
26,818
-53,128
-66% -$784K 0.12% 178
2022
Q2 		$935K Buy
79,946
+69,837
+691% +$431K 0.41% 74
2022
Q1 		$62K Buy
+10,109
New +$74.4K 0.03% 183
2021
Q4 		– Sell
-16,977
Closed -$192K – 267
2021
Q3 		$192K Buy
+16,977
New +$206K 0.02% 286

Other funds holding ALT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Atom Investors's ALT Position: Q1 2024 in Review

Atom Investors sold out of Altimmune (ALT) in Q1 2024, closing a stake of 27,412 shares — an estimated $308K sold.

Atom Investors first reported a position in ALT in Q3 2021 and held it in 5 quarters. The position peaked at $935K in Q2 2022. 172 funds tracked by Wall St. Rank hold ALT as of Q1 2024.

  • Atom Investors reported no remaining Altimmune position as of Q1 2024 after selling out during the quarter.
  • Atom Investors sold 27,412 Altimmune shares in Q1 2024, an estimated $308K.
  • Atom Investors first reported a position in Altimmune in Q3 2021 and held it in 5 quarters.
  • Atom Investors's Altimmune position peaked at $935K in Q2 2022.
  • 172 funds tracked by Wall St. Rank held Altimmune as of Q1 2024.

Based on Atom Investors's 13F filing for Q1 2024, filed 15 May 2024.